The Facilities for Medicare and Medicaid Providers not too long ago introduced—with out rationalization—that it might not proceed with a proposal initiated by the Biden Administration to cowl weight-loss medicine like Wegovy and Zepbound for its beneficiaries.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
